When and how to use longer durability therapies in neovascular age-related macular degeneration (nAMD).
Credit available for this activity expires: 10/27/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002961?ecd=bdc_podcast_libsyn_mscpedu